Sponsor:
University of Central Florida
Code:
NCT05838638
Conditions
Neoplasms
Chemotherapy-induced Nausea and Vomiting
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Interventions
eSSET-CINV
Brief summary:
Conditions
Neoplasms
Chemotherapy-induced Nausea and Vomiting
Study ID
NCT05838638
Start date
Jun 9, 2023
Status verified date
May, 2025
Completion date
Jun 30, 2027
Anticipated
Primary completion date
Jun 30, 2027
Anticipated
Eligibility Criteria
Sex: All
Age: 60+
Healthy Volunteers: Not accepted
Enrollment
610 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Supportive Care
Arms
experimental: Intervention
active comparator: Control
Interventions
eSSET-CINV
Primary outcome measure
Central contacts
Locations
Miller School of Medicine Sylvester Comp. Cancer Center
Recruiting
Miami, Florida, United States, 33136
Contacts
Deborah Anglade, PhD
d.anglade@miami.eduOrlando Health
Recruiting
Orlando, Florida, United States, 32806
Contacts
Aurea Middleton, MSN
aurea.middleton@orlandohealth.comSponsor
University of Central Florida
Last update posted
May 1, 2026
Last verified
May, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Central Florida on 2026-05-01.